First Tracks Biotherapeutics, Inc. (TRAX)

TRAX Statistics

Total Valuation

TRAX has a market cap or net worth of $556.88 million. The enterprise value is $270.43 million.

Market Cap	556.88M
Enterprise Value	270.43M

Important Dates

The next estimated earnings date is Monday, June 1, 2026.

Earnings Date	Jun 1, 2026
Ex-Dividend Date	n/a

Share Statistics

TRAX has 34.89 million shares outstanding.

Current Share Class	34.89M
Shares Outstanding	34.89M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.82%
Owned by Institutions (%)	8.82%
Float	31.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.16
P/TBV Ratio	2.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.74

Current Ratio	8.74
Quick Ratio	8.65
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-70.12%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.63M
Employee Count	104
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	41.53
Average Volume (20 Days)	433,416

Short Selling Information

The latest short interest is 3.92 million, so 11.22% of the outstanding shares have been sold short.

Short Interest	3.92M
Short Previous Month	4.03M
Short % of Shares Out	11.22%
Short % of Float	12.60%
Short Ratio (days to cover)	12.58

Income Statement

Revenue	n/a
Gross Profit	-139.61M
Operating Income	-180.54M
Pretax Income	-169.38M
Net Income	-169.38M
EBITDA	-180.00M
EBIT	-180.54M
Earnings Per Share (EPS)	-$4.85

Balance Sheet

The company has $286.46 million in cash and n/a in debt, with a net cash position of $286.46 million or $8.21 per share.

Cash & Cash Equivalents	286.46M
Total Debt	n/a
Net Cash	286.46M
Net Cash Per Share	$8.21
Equity (Book Value)	257.46M
Book Value Per Share	7.38
Working Capital	256.29M

Cash Flow

In the last 12 months, operating cash flow was -$130.48 million and capital expenditures -$69,000, giving a free cash flow of -$130.55 million.

Operating Cash Flow	-130.48M
Capital Expenditures	-69,000
Depreciation & Amortization	538,000
Net Borrowing	n/a
Free Cash Flow	-130.55M
FCF Per Share	-$3.74

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TRAX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-30.41%
FCF Yield	-23.44%

Analyst Forecast

The average price target for TRAX is $39.29, which is 146.18% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$39.29
Price Target Difference	146.18%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1